Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency
-
Published:2018-12
Issue:
Volume:160
Page:1-9
-
ISSN:0166-3542
-
Container-title:Antiviral Research
-
language:en
-
Short-container-title:Antiviral Research
Author:
Pichon Maxime,
Picard Caroline,
Simon Bruno,
Gaymard AlexandreORCID,
Renard Cécile,
Massenavette Bruno,
Malcus Christophe,
Monneret GuillaumeORCID,
Morfin-Sherpa Florence,
Valette MartineORCID,
Javouhey Etienne,
Millat GillesORCID,
Lina Bruno,
Josset Laurence,
Escuret VanessaORCID
Funder
Santé Publique France
Subject
Virology,Pharmacology
Reference44 articles.
1. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets;Abed;J. Virol.,2014
2. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child;Baz;Clin. Infect. Dis.,2006
3. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial;Beigel;Lancet Infect. Dis.,2017
4. Dissemination of scientific software with Galaxy ToolShed;Blankenberg;Genome Biol.,2014
5. A global initiative on sharing avian flu data;Bogner;Nature,2006
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献